Balrampur Chini PLA plant: ₹2,000 cr sales in FY27

Introduction

Balrampur Chini Mills Limited (BCML) is expanding beyond sugar into bioplastics through a new Poly Lactic Acid (PLA) plant in Uttar Pradesh. The company expects the unit, once it reaches full utilisation, to generate around ₹2,000 crore in annual revenue. A senior company executive said commissioning is expected in the third quarter of the current financial year, which corresponds to the October to December quarter. The project is positioned as a forward integration move, using agricultural feedstock and existing infrastructure around the company’s sugar operations. PLA is typically used as a biodegradable alternative to conventional plastic in packaging and other applications. The company has also indicated that the full financial impact of the project will be visible in FY28 (2027-28). The announcement is material for investors because it adds a large, non-sugar revenue stream with a stated profitability target.

What the PLA plant will produce

The upcoming facility is designed to manufacture polylactic acid, a biodegradable plastic. The article describes biodegradable products as those that can decompose relatively easily in soil and similar environments. BCML has said the plant will focus on bioplastic production at industrial scale. The project has been framed as part of a sustainability-aligned diversification strategy. The company has also linked the move to broader environmental goals, including India’s net-zero ambition for 2070, in earlier public statements included in the provided text. The plant is intended to shift the business mix toward “green products” over time, with a company statement pointing to more than 50% of product mix becoming green products by FY27-28.

Capacity and project scale

BCML has disclosed an annual capacity of 80,000 tonnes per annum (TPA) for the PLA unit in the Hindi interview-based report. Separate company statements in the provided text also refer to a 75,000 TPA initial capacity, with scope for future expansion. The facility is planned as a greenfield unit adjacent to an existing sugar mill in Uttar Pradesh, allowing the company to leverage existing infrastructure. The scale is significant compared with BCML’s current profile as an integrated sugar producer. In one disclosure, BCML described it as India’s first “industrial bioplastic” plant.

Commissioning timeline and ramp-up

A BCML executive said operations are expected to begin in Q3 of the current financial year (October to December quarter). Another project update included in the provided text says the plant is expected to be commissioned in Q3 FY27. In practical terms, both references point to commissioning around the October to December window, depending on how the financial year is defined in the statement. BCML has also said the complete financial impact will be visible in FY28 (2027-28), which indicates a ramp-up period after commissioning. In a television transcript excerpt, the executive referenced a timeline of around 30 months for commercial production to start, consistent with a phased build and commissioning process.

Investment, spending so far, and equipment readiness

The investment estimate in the provided material varies across disclosures. The Hindi report cites a total investment of more than ₹3,000 crore for the 80,000 TPA plant. Separate company communication included in the text describes a ₹2,000 crore forward integration project, with investment planned in phases over the next 30 months. As of January 31, 2026, the company had spent about ₹1,421 crore on the PLA project, according to the project update provided. The same update said 90% of imported equipment was already at the site, and that construction activities were in full swing. These datapoints suggest the project has progressed beyond early planning and procurement.

Revenue potential and profitability targets

BCML expects around ₹2,000 crore of annual revenue from the PLA plant at full capacity, as stated by the executive director and repeated in the project update. Another disclosure in the provided text places annual revenue potential at about ₹1,700 to ₹1,800 crore. The project update also mentions an anticipated EBITDA margin of 35% at full capacity. The company has not provided a quarter-by-quarter revenue split in the text, and it has clearly indicated the full impact will show up in FY28 (2027-28). For context, BCML’s total revenue in the last financial year cited in the report was about ₹6,300 crore, which indicates that PLA could become a meaningful contributor once stabilised.

Policy support from Uttar Pradesh

The provided material highlights support under the Uttar Pradesh State Government’s Bio Plastic Industrial Policy 2024. The incentives listed include a 50% capital subsidy and a 5% interest subvention. Such incentives can reduce the effective cost of project execution and financing, especially for large greenfield manufacturing units. The policy support is relevant because the project involves imported equipment and long gestation, both of which can pressure returns if funding costs rise. However, the article does not quantify the incentive benefit in rupee terms, so any numerical impact on project economics remains undisclosed.

How BCML’s recent financials frame the expansion

BCML’s consolidated net profit fell to ₹378.46 crore in FY26 (2025-26) from ₹436.92 crore in FY25 (2024-25), as per the numbers in the provided report. At the same time, total income rose to ₹6,307.95 crore in FY26 from ₹5,504.19 crore in FY25. This combination of higher income but lower profit underscores why management is emphasising diversification and margin-led growth in new segments. The company’s stated EBITDA margin target for PLA, if achieved at scale, would be closely watched against the volatility that can affect sugar-linked earnings.

Market impact and what investors may track

From a market perspective, the PLA project changes BCML’s narrative from a sugar and ethanol-linked company to a broader bio-based materials player. The most immediate datapoints to track are commissioning in Q3 FY27, ramp-up progress, and whether the company reiterates the ₹2,000 crore revenue potential and 35% EBITDA margin as operations begin. Investors may also watch for clarity on the final capex number, since disclosures range from ₹2,000 crore (phased) to over ₹3,000 crore. Another operational indicator is procurement completion, where BCML has already said 90% of imported equipment was on-site as of January 31, 2026. Policy incentives under UP’s Bio Plastic Industrial Policy 2024 may also influence funding and execution timelines.

Key facts at a glance

Conclusion

BCML’s PLA plant is a large diversification bet, with management pointing to ₹2,000 crore annual revenue potential and a 35% EBITDA margin at full utilisation. The company has indicated commissioning in the October to December quarter and expects the full financial impact to be visible in FY28 (2027-28). With ₹1,421 crore already spent as of January 31, 2026 and most imported equipment at the site, the next set of updates will likely focus on commissioning readiness and the pace of ramp-up.